Instrument Inactif

Communiqués Enfusion, Inc.

Actions

ENFN

US2928121043

Logiciels

Communiqués

02/04/25	ENFUSION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Enfusion, Inc. - ENFN	BU
03/03/25	Enfusion Announces Fourth Quarter and Full Year 2024 Results	BU
14/01/25	ENFUSION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Enfusion, Inc. - ENFN	BU
17/12/24	Orbus Software Announces Strategic Growth Investment from FTV Capital and SilverTree Equity	AQ
20/11/24	Enfusion To Present at Upcoming Investor Events	BU
04/11/24	Enfusion : Third Quarter 2024 Shareholder Letter	PU
04/11/24	Enfusion Announces Third Quarter 2024 Results	BU
10/10/24	Enfusion Announces Key Leadership Team Additions to Drive Client Success and Fuel Innovation	BU
03/10/24	Enfusion Announces Date of Third Quarter 2024 Results	BU
24/09/24	ZEMA Global Data Corporation to Acquire Morningstar Commodity Data	AQ
06/08/24	Enfusion : Second Quarter 2024 Shareholder Letter	PU
06/08/24	Enfusion Announces Second Quarter 2024 Results	BU
05/08/24	Enfusion Introduces the Next Phase of Portfolio Workbench, Empowering Asset Managers with Increased Efficiency and Flexibility	AQ
02/08/24	Enfusion Introduces the Next Phase of Portfolio Workbench, Empowering Asset Managers with Increased Efficiency and Flexibility	BU
16/07/24	Enfusion Announces Date of Second Quarter 2024 Results	BU
05/06/24	Enfusion : William Blair 44th Annual Growth Stock Presentation	PU
29/05/24	Enfusion To Present at Upcoming Investor Events	BU
09/05/24	Enfusion Announces First Quarter 2024 Results	BU
18/04/24	Enfusion Announces Date of First Quarter 2024 Results	BU
17/04/24	Matt Campobasso: "The Legal Team Has To Be Able To See Around Corners"	AQ
21/03/24	Kayne Anderson Strengthens Investment Operations After Successful Platform Migration to Enfusion	BU
12/03/24	Enfusion Announces Fourth Quarter 2023 Results and Full Year 2023 Results	BU
13/02/24	Enfusion Announces Date of Fourth Quarter and Full Year 2023 Results	BU
12/02/24	Enfusion to Host Investor Day on March 19, 2024	BU
18/01/24	Enfusion Elevates Valeria Gutowski to Chief Accounting Officer	BU